<img alt="" height="1" width="1" />
GlaxoSmithKline: Human Genome Sciences Files BLA For Benlysta
Wall Street Journal
LONDON (Dow Jones)--GlaxoSmithKline PLC (GSK.LN), a global pharmaceutical and healthcare company, said Thursday that Human Genome Sciences Inc. (HGSI) has submitted a Biologics License Application to the US Food and Drug Administration, for Benlysta ...
Human Genome Sciences says cancer drug fails studyBusinessWeek
Human Genome says cancer drug fails to improve survivalReuters
Human Genome Sciences Announces Submission of Biologics License Application to ...MarketWatch (press release)
Daily Markets -Pharmaceutical Online (press release) -FierceBiotech
all 70 news articles »
More...